Overview
- 11 inspections across 11 sites are on record.
- 36 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-20.
At a glance
Inspections
11
Sites
11
Observations
36
Career since
Jan 2025
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bausch & Lomb Incorporated | 20 Mar 2026 | Human Drugs | On file |
| Tarmac Products, Inc. | 6 Feb 2026 | Human Drugs | View 483 → |
| Kingdomway Health Sciences LLC | 3 Dec 2025 | Human Drugs | View 483 → |
| Pure Source, LLC | 21 Oct 2025 | Human Drugs | View 483 → |
| Transpire Bio Inc | 1 Oct 2025 | Human Drugs | View 483 → |
Sites inspected
Bausch & Lomb IncorporatedTampa, United States1 insp.
Tarmac Products, Inc.Miami Gardens, United States1 insp.
Kingdomway Health Sciences LLCCasa Grande, United States1 insp.
Pure Source, LLCDoral, United States1 insp.
Transpire Bio IncWeston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer Lalama3 shared
Ronda R Loyd Jones2 shared
Joanne E King2 shared
Damaris Y Hernandez1 shared
Santos E Camara1 shared
Michael Z Weigman1 shared
Milton J De Jesus Tavarez1 shared
Saundrea A Munroe1 shared
Full investigator report
Get the verbatim findings behind Mickell Smith's 36 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site